 |
|
|
|
|
|
|
|
|
|
|
|
1 to 5 of 5 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Jayachandran A, Rao K. on NEWS: Persistence of (Worm) Memory Depends on Calsyntenin/Alcadein Ortholog, The authors introduce an intriguing and novel thought on the memory concept in C.... 11 Apr 2008.
|
|
|
 |
|
|
Rao K, Shrikanth Gadad B. on NEWS: Chew ’em Up and Spit ’em Out: Aβ Leaves Cells via Exosomes, I strongly recommend this article. But what percent of amyloid-β is bound to exosomes in AD is... 28 Jul 2006.
|
|
|
|
|
|
Rao K, Shrikanth Gadad B. on NEWS: ER-Golgi Traffic Jam Explains α-Synuclein Toxicity, The role and precise function of α-synculein in Parkinson disease is still shrouded in mystery.... 28 Jul 2006.
|
|
|
|
|
|
Gupta V, Rao K. on NEWS: MCI—Hippocampal IDE, Parahippocampal White Matter in Decline, Neuronal Loss Specific to Hippocampus in AD
Regional specificity of neuronal... 5 Jul 2006.
|
|
|
|
|
|
Gupta V, Rao K. on NEWS: NO Laughing Matter—Nitrosylation of Isomerase Spells Trouble for Neurons, Amyloid-β peptides induce DNA fragmentation: an alternative pathway yet to be understood in... 9 Jun 2006.
|
|
|
|
|
|
|
1 to 5 of 5 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
